Kosan, Meiji Seika polyketide deal

The companies will collaborate to develop a broad-spectrum antibiotic for resistant bacteria. KOSN will develop a polyketide in one of its host organisms for Meiji Seika Kaisha (Tokyo, Japan). KOSN al...